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The presence of  viruses  in  apparently healthy  animals has  not  infre- 
quently complicated experimental procedures.  Previous investigators have 
discovered various viruses in mice from different highly inbred laboratory 
stocks.  Marchal  (1)  described a  natural disease which occurred in stock 
mice and was caused by infectious ectromelia virus.  Traub (2) isolated a 
virus from normal white mice and subsequently found it  to be identical 
with lymphocytic choriomeningitis virus described by Armstrong and Lillie 
(3).  Theiler  (4)  observed spontaneously paralyzed mice in an otherwise 
normal stock and isolated the causal agent, mouse encephalomyelitis virus. 
Viruses  capable  of producing fatal  pneumonia in  mice have  been found 
previously in normal mouse lungs by Dochez, Mills, and Mulliken (5) and 
Gordon, Freeman, and Clampit (6). 
During the fall of 1938 attempts were made to isolate viruses from naso- 
pharyngeal washings obtained  from patients  with  various  acute  non-in- 
fluenzal diseases of the respiratory tract.  In the course of these experi- 
ments  washings  from  patients  with  common  cold,  sporadic  grippe,  so 
called  "primary atypical pneumonia," or pneumococcus pneumonia were 
inoculated intranasally  in  mice.  Suspensions of  the lungs of inoculated 
mice were passed in series to other mice in an attempt to determine whether 
or not viruses potentially pneumotropic for mice were present in any of the 
washings.  In almost every mouse passage series transmissible pulmonary 
consolidations occurred  after  a  few passages.  To  determine the  signifi- 
cance of these results serial mouse lung passages were carried in normal 
stock mice, and in these series, too, transmissible pulmonary consolidations 
were encountered.  By means of serial passage a virus capable of producing 
fatal pneumonia in mice was isolated from the lungs of apparently healthy 
mice.  A  preliminary note  concerning this  virus  has  already  been  pub- 
lished  (7). 
Mice  are  extensively used  in  studies of  epidemic influenza  and  other 
acute infections of the respiratory tract.  The frequency with which it is 
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necessary to  resort  to  serial  mouse lung passage  in  attempts  to  establish 
strains  of human influenza virus  in  mice  has  made  it imperative  to  learn 
as much as possible of the characteristics of this new virus found in normal 
mouse lungs.  This information should assist  in  the  recognition of lesions 
produced by this agent and may eliminate the possible confusion of results 
due  to its presence. 
It is  the  purpose  of  this  paper  to  report  the  isolation  of  a  number  of 
strains  of a  pneumotropic virus from normal mouse lungs and  to present 
the  results  of  studies  designed  to  determine  some  of  its  characteristics. 
Evidence  that  this  virus  is  different  from  the  viruses  which  have  been 
found in  normal mouse lungs by other  investigators  (5,  6)  will  be  given. 
Material and Methods 
Mice.--Albino Swiss mice between 3½ and 4 weeks of age were used throughout this 
study.  These were obtained at weekly intervals  from eight separate  commercial breed- 
ers in the vicinity of New York City.  It is known that three of the breeders obtained 
their  original  breeding  stock from  one  source.  The  mice  appeared  to  be  perfectly 
healthy, and numerous groups held for observation  failed to develop any signs of illness 
during periods of several weeks.  Spontaneous  pulmonary consolidation, which usually 
affected only a portion of one lobe, occurred with about equal frequency (1 to 2 per cent) 
in the mice from the various  breeders. 
Serial Mouse Lung Passages.--Groups of six mice were killed and their lungs removed 
aseptically.  The lungs from each group were pooled and ground in a mortar with crystal- 
line alundum; and sufficient beef infusion broth was added to make approximately  10 or 
20 per cent suspensions.  After the suspensions were centrifuged for 15 minutes at about 
2500 g.P.,J, the supernatant fluid was withdrawn.  Groups of six mice were inoculated 
intranasally  with the supernatant from each of the centrifuged  lung suspensions.  All 
intranasal  inoculations  were done under ether anesthesia  using 0.05 cc. of the material. 
Passages to other groups of mice were made in some series at 4 to 5 day intervals  and in 
others at 7 to 9 day intervals.  Cultures  of the lung suspensions were made regularly 
to determine  sterility. 
Interpretation of Results by Means of Numerical Infectivity Scores.--For  the purpose 
of expressing in uniform terms  the results  obtained in a group of mice by the various 
experimental  procedures,  it has been found useful to determine  the additive numerical 
infectivity score for each of the groups.  The details of this scoring method as applied 
to the studies on epidemic influenza virus have already been described (8).  This method 
was found to be satisfactory in the interpretation of results obtained with the pneumonia 
virus of mice.  In the tables to be presented  the numerical infectivity score is given as a 
fraction, the denominator indicating the number of mice in the group, and the numerator 
indicating  the sum of the individual  infectivity scores obtained for each mouse in the 
group.  Thus, death of a mouse with 4/4 of lungs consolidated  =  5; survival with 4/4, 
~, ~, or ~  of lungs consolidated  = 4, 3, 2, and 1, respectively.  The maximum possible 
infectivity score,  caused  by death  of  all  mice  in  a  group,  therefore,  =  5  X  the 
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EXPEI~  ~ENTAL 
Incidence of Virus Carriers among Normal Mice and Isolation of Virus.- 
In the initial serial mouse  lung passages no distinction was made between 
the  mice  obtained  from  the  eight  different  breeders,  and  groups  of mice 
from any one of the breeders were used in each successive passage.  A total 
of thirty-one  separate series was carried  through  four or more serial  pas- 
sages made at 7 to 9  day intervals in these experiments.  From twenty, or 
65 per cent,  of these thirty-one  series a  virus capable of  producing  trans- 
missible pulmonary consolidation in  mice was isolated.  Definite evidence 
of pneumonia  was noted  in  these  twenty series after  an  average  of  four 
serial passages.  In  certain  of the  series definite pulmonary  consolidation 
occurred as soon as the second passage, while in some others it did not de- 
velop until  the seventh passage.  Fatal pneumonia was produced as early 
as  the  third  passage,  but on  the  average  deaths  did not  occur  until  the 
fifth  passage. 
The frequency with which the virus was encountered in these series made 
it important  to determine whether it was present in the mice of all or only 
some of the individual breeders.  Eight  separate  serial passages were ini- 
tiated  with suspensions of lungs from groups of mice obtained from each 
of the eight breeders, and each series was subsequently carried in mice of 
the same breeder.  Transfers were made at 4 to 5 day intervals.  The re- 
sults  were  entirely  negative.  Although  an  average  of  nineteen  serial 
passages was carried out in each series, no evidence was obtained indicat- 
ing the presence of a virus capable of producing pneumonia. 
After a varying numberof passages at 4 to 5 day intervals, parallel branch 
series were initiated  and were passed at 7  to 9 day intervals.  The results 
are shown in Table I.  It will be noted that in mice obtained from breeders 
1, 2, and 3, definite pulmonary consolidation occurred on the second, first, 
and  second passages,  respectively, in  the branch  series maintained  at  the 
7 to 9 day interval.  From these three series the virus was readily isolated. 
On  the  other  hand,  in  mice from  the  remaining  five breeders no  definite 
pulmonary  consolidations  were  observed,  even  though  an  average  of  six 
passages at the 7 to 9 day interval was carried  out.  The ease with which 
the  presence  of  the  virus  was  demonstrated  in  mice  from  breeders  1,  2, 
and  3  made  it  seem  unlikely  that  the  agent  was present  in  mice  of the 
other breeders. 
Experimental Disease in Mice.--Mice  which were inoculated with  the virus intra- 
nasally appeared  to remain perfectly healthy for 5 to 7 days; then  they became less 
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weight until later, when moribund, they appeared thin and emaciated.  Sick mice had 
ruffled, dirty fur and sat hunched  up on their bedding.  Respiration was slower and 
deeper than normal and sometimes labored.  Often there was cyanosis of the ears and 
tail.  Mice infected with small doses of the pneumonia virus often did not die until 
the 12th or 13th day, whereas those infected with influenza virus very rarely died later 
than the 9th day after inoculation (8). 
Pathology.--Mice  which  died after the intranasal inoculation of the virus did not 
always show as extensive or regularly distributed pulmonary consolidations as those in 
mice infected with epidemic influenza virus.  Not infrequently the consolidations were 
found to affect no more than  ~  or ~  of the lung.  Occasionally mice which had been 
killed while moribund showed consolidation of less than ~  of the lung.  Macroscopically 
the lesions appeared somewhat different from those produced by influenza virus.  They 
TABLE  I 
Results of Serial Mouse Lung Passages at 4 to 5 Day Intervals Followed by Branch Series 
at 7 to 9 Day Intervals with Mice from Eight Breeders 
Mouse 
breeder 
Interval 
days 
1  4--5 
2  4-5 
3  4-5 
4  4-5 
5  4-5 
6  4-5 
7  4-5 
8  4-5 
Serial passage 
Initial  Secondary 
Number of 
passages 
8 
9 
7 
13 
7 
4 
5 
6 
Pulmonary 
:ousolidation  Interval 
days 
0  7-9 
0  7-9 
0  7-9 
0  7-9 
0  7-9 
0  7-9 
0  7-9 
0  7-9 
Number of 
passages 
2 
1 
2 
6 
6 
11 
3 
5 
Passage 
showing 
pulmonary 
consolidation 
10 
10 
9 
0 
0 
0 
0 
0 
Pneumonia 
virus 
isolated 
+ 
+ 
+ 
0 
0 
0 
0 
0 
were more hilar in distribution in the early stages and later tended to radiate outward 
along the bronchi.  The lesions were less plum-colored, less dense, and less homogeneous 
than  those observed in  experimental influenza and often had  a  striated appearance. 
However, it was seldom possible to distinguish definitely between two individual lungs 
in which the respective consolidations had been produced by these two different viruses. 
Microscopically the lesions were not strikingly different from those due to influenza 
virus.  The bronchi and blood vessels were surrounded by dense and often quite bulky 
accumulations of cells which were largely mononuclear.  The alveolar septa were thick- 
ened and contained cellular exudate.  The alveoli contained fluid and varying numbers 
of mononuclear and red blood cells.  Polymorphonuclear leucocytes were seldom seen 
except in the exudates in the bronchial lumena in which they were numerous.  The 
bronchial epithelium was  regularly well preserved and  often  appeared to  be  hyper- 
plastic. 
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bacterial  organisms from suspensions of mouse lungs infected with the virus.  Although 
bacteria were isolated  occasionally from these suspensions, none of those studied were 
found capable of producing transmissible pneumonia in mice after intranasal inoculation. 
Approximately 85 per cent of the suspensions  of infected  mouse lungs  proved to be 
sterile in beef infusion broth and on blood-agar plates. 
Pleuropneu~ia-Like Organisms.--Suspensions of mouse  lungs  were also  cultured 
on 30 per cent normal horse  serum  agar plates after the method of Klieneberger  (9). 
The serum  was filtered  through a  Berkefeld  V candle  and then through a  Seitz pad 
before it was mixed with the agar.  Only a small central portion of the surface of each 
serum agar plate was inoculated, and the remainder of the plate, which had been streaked 
with  sterile  broth,  was used  as  a  control.  The plates  were incubated at 37°C. and 
were observed  for 6 days.  When pleuropneumonia-like  colonies were seen under the 
microscope, small blocks of serum agar carrying a few colonies were removed and trans- 
ferred  to 10 per cent normal rabbit serum  broth which had been filtered  in a manner 
identical  with that described  above.  The serum  broth cultures  were transferred  at 2 
day intervals.  Antisera against these  organisms  were prepared in rabbits.  For this 
purpose the organisms  contained  in 30 cc. of serum broth culture were sedimented  in 
the open-air angle centrifuge at 13,000 ~.P.~. for 30 minutes, and were then resuspended 
in 3.0 cc. of 0.85 per cent NaC1.  Suspensions prepared in this manner were injected 
intraperitoneally in rabbits,  and 10 to 12 days later serum was obtained by intracardiac 
puncture. 
The pleuropneumonia-like  organisms were isolated from suspensions of consolidated 
mouse  lungs  with  relative  ease.  At the same  time no diificulty  was experienced  in 
isolating similar organisms from mouse lungs which did not contain the virus as well as 
from those infected  with epidemic influenza virus.  The number of colonies of pleuro- 
pneumonia-like  organisms  produced by these  three  different  varieties  of mouse lung 
suspensions was approximately the same.  The organisms were readily  subcultured  in 
rabbit  serum  broth, and these  cultures  failed  to produce any evidence  of pulmonary 
consolidation after the intranasal inoculation of mice.  The mixture of large numbers of 
pleuropneumonla-like  organisms  with small amounts of the virus  did not increase  the 
extent or the severity of the pneumonia produced in mice by the virus.  Rabbit antisera 
which were capable  of producing macroscopic agglutination of the mouse pleuropneu- 
monia-like organisms failed to show evidence of neutralizing  capacity when they were 
tested against 100 lethal doses of the pneumonia virus of mice.  These antisera likewise 
failed to neutralize a similar amount of epidemic influenza virus. 
Physical Characteristics of the Virus 
StabiUty.--The  virus  was  completely inactivated  in  suspensions  of  in- 
fected mouse lungs which were heated to 56°C.  for 30 minutes.  Even at 
room temperature the virus rapidly became inactivated,  and in broth sus- 
pensions  the  infectious  titer  frequently  decreased  one  hunctredfold  in  1 
hour.  The  addition  of  10 per  cent normal horse  serum  to  virus  suspen- 
sions reduced the rate of inactivation at room temperature, and under these 
conditions  the  infectious  titer  seldom  decreased  more  than  fivefold  in  1 
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cabinet  (10)  at  -  76°C. without noticeable decrease in infectious titer, and 
suspensions in 20 per cent normal horse serum were found to be active after 
desiccation in  the  frozen state. 
Centrifugation.-- 
Suspensions  of infected mouse lungs in 2 per cent normal horse serum broth were 
centrifuged both in the open-air angle centrifuge described by Bauer and Pickels (11) 
and in the high speed vacuum centrifuge developed by the same authors (12).  Celluloid 
tubes containing 6 cc. of the suspensions  were run at 13,000 R.P.~. for 30 minutes in the 
former apparatus  and  at  27,000 ~.P.M. for 60  minutes  in  the latter.  Samples were 
removed at various levels from the centrifuged specimens by means of the device de- 
scribed by Hughes, Pickels, and HorsfaU (13).  Serial decimal dilutions of these samples 
were tested for the presence of virus by the intranasal inoculation of groups of six mice. 
The results indicated that after centrifugation at 13,000 R.P.M. for 30 min- 
utes there  was only partial  sedimentation  of the  virus,  whereas after cen- 
trifugation  for 60 minutes at  27,000  R.P.M.  it was almost completely sedi- 
mented. 
Ultrafiltration.--The  virus  passed  readily  through  Berkefeld  V  and  N 
candles  but  not  Seitz  filters.  A  number  of  ultrafiltration  experiments 
were carried out  using graded  collodion  membranes of the  Elford type as 
prepared  by  Bauer  and  Hughes  (14). 
As a source of virus, suspensions  of infected mouse lungs in 10 per cent normal horse 
serum broth were centrifuged for 30 minutes at 2500 R.P.~., and the supernatant liquid 
was then  diluted  1 to  10 with a  similar diluent.  This was quickly filtered through 
membranes with an average pore diameter of approximately 800 m/~.  Portions of this 
stock filtrate were then passed through a series of collodion membranes of varying porosi- 
ties and the infectivity of the filtrates was tested by intranasal inoculation into groups 
of five or six mice.  In a number of instances duplicate groups of mice were used for each 
ultrafiltrate.  Both groups were kept under observation for 14 days, at the end of which 
period mice of one group were killed and their lungs examined for the presence of pul- 
monary consolidation.  The mice of the second group, however, were then reinoculated 
intranasally  with  100 lethal  doses of the  virus  to  determine the  presence of active 
immunity. 
The  results  obtained  with  one of the  strains  of the  virus  are  shown  in 
Table II.  It will be noted that a  sufficient amount of virus passed through 
membranes with  an A.P.D.  of 400  m/z or larger not  only to produce pneu- 
monia in mice but also to render them actively immune to a  second intra- 
nasal  inoculation  of  unfiltered  virus.  The  virus  has  passed  through 
membranes  having  an  A.P.D.  of  348  m/z,  but  not  through  those  with  an 
A.P.D.  of 300 m/z or smaller. 
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ticularly because of the relatively low titer of infected mouse lung suspen- 
sions, it has been very difficult to determine accurately the ultrafiltration 
end  point.  It  is  realized  that  the  virus  may actually  be  considerably 
smaller than these ultrafiltration results would indicate, but in the absence 
of suspensions of high titer it seems impossible to arrive at anything more 
than a rough approximation of particle size.  Within the limits permitted 
by the present data the virus appears to have a diameter of approximately 
100  to  150 In#. 
TABLE  II 
Results of Ultrafiltration of Pneumonia Virus 
Average pore diameter  of 
membranes 
707 
612 
528 
502 
409 
348 
301 
230 
200 
154 
106 
Control, stock filtrate 
Infectivity test  Immunity  test 
Intranasal inoculation of  Intranasal inoculation of 
ultratiltrate  ultratiltrate, reinoculated with i00 
lethal doses after 14 days 
Died  Survived  Infectivity 
score  Died 
6 
1 
0 
1 
0 
0 
0 
0 
0 
0 
0 
S  •  .  J Infectivity 
urvlvea  score  : 
0  30/6 
5  7/6 
6  I  12/6 
11  I  8/12 
6  7/6 
12  2/12 
6  0/6 
11  0/11 
12  0/12 
11  0/11 
12  0/12 
0  30/6 
2 
1 
1 
5 
6 
6 
t 
15/6 
12/6 
10/6 
26/6 
30/6 
30/6 
Biological Characteristics of the Virus 
Virulence for Mice.--As may be assumed from the fact that the virus is 
harbored in  apparently healthy mice, its  initial virulence was low.  The 
virulence increased gradually as passages were continued until eventually 
fatal pneumonia ensued.  With  some of the most virulent strains 5.0  X 
10 -6 gm. (or 0.05  cc. of a  10 -4 dilution) of infected lung sufficed to produce 
death from pneumonia.  However, the infectious titer of a  single suspen- 
sion of one strain of the virus depended to a  considerable extent upon the 
source of the mice in which it was tested.  In Table III are shown the re- 
sults of a  series of fitrations of one strain of the virus done simultaneously 
in mice from each of the eight breeders.  Titration  end points were cal- 398  A  PNEUMONIA  VIRUS  CARRIED  BY  NORMAL  MICE 
culated by the method of Reed and Muench  (15).  The titers were found 
to  be  practically identical  in  the  three  varieties  of  mice  which  had been 
shown  to  carry the  virus,  but  varied  widely in  the  mice  from the  other 
five sources.  The 50 per cent mortality end point was 10  -~'3 in mice from 
breeder  4,  while  it  was  10  -5.°  in  mice  from breeder  6.  The  amount  of 
virus necessary to produce fatal pneumonia in mice from these two sources, 
therefore, differed by approximately 600 times. 
Evidence  that the virus was far more infectious  for mice than was indicated  by the 
production of pulmonary consolidation  by various  dilutions  was  obtained indirectly 
by testing for the presence of active immunity.  Groups of mice were inoculated  intra- 
nasally  with decimal dilutions  from 10  -1 to  10  -7 of one strain of the virus and were 
TABLE  HI 
Results of Simultaneous  Titrations  of Strain 15 Pneumonia  Virus in Mice from 
Eight Breeders 
Mouse breeder  Pneumonia virus carriers 
+ 
+ 
+ 
0 
0 
0 
0 
0 
Titration end points 
50 per cent mortality 
Jog 
--3.9 
--3.8 
--3.8 
--2.2 
--2.4 
--5.0 
--3.1 
--3.8 
50 per cent pulmonary 
consolidation 
--5.1 
--5.4 
--5.5 
--3.2 
--3.6 
--5.8 
--4.4 
--5.0 
observed for an interval of 14 days.  At the end of this period the mice which had sur- 
vived in the groups that had received dilutions  10  -2 to 10  -4 were killed and their lungs 
examined for the presence of pulmonary consolidation.  However,  those groups which 
had been given 10  -s to 10  -7 dilutions were not killed at the end of the observation period, 
but instead they were reinoculated  intranasally with ten lethal doses of the virus.  A 
group of normal mice from the same breeder and of the same age were inoculated  simul- 
taneously with an identical amount of virus to serve as controls.  All were observed for 
an additional  14 day period.  The results  of this experiment  are shown in Table IV. 
It will be noted that fatal pneumonia was not produced with a dilution greater than 10  -~, 
and that only two of five mice inoculated  with the 10  -4 dilution  of the virus developed 
small areas of pulmonary consolidation.  Nonetheless, mice which were inoculated with 
both the 10  -5 and 10  -6 dilutions  of the virus were found to be solidly immune to the 
subsequent  intranasal inoculation of ten lethal doses of the virus.  On the basis of these 
observations  1/10,000 lethal dose or 1/100 infectious dose of this virus appears  capable 
of conferring active immunity in mice after intranasal inoculation. FRANK  L.  HORSFALL, JR.,  AND  RICHARD G.  HAHN  399 
The virus failed entirely to infect mice except when given by  the in- 
tranasal route.  Repeated attempts to infect them by intracerebral, intra- 
peritoneal,  intravenous,  intramuscular,  and  subcutaneous  routes  were 
regularly ineffective.  Serial intranasal passages of the brains of mice that 
had received virus intracerebraUy, or of the livers of mice that had been 
given virus intraperitoneally, failed  to  produce pulmonary consolidation 
in the test mice.  The virus appears, therefore, to be strictly pneumotropic 
for mice. 
Attempts to produce infection in  normal mice by  contact with  those 
which had been given the virus intranasally were uniformly unsuccessful. 
A  total of 64 normal mice were placed in the same jars with mice which 
TABLE  IV 
Results of Reinoculation with Pneumonia  Virus in Mice Which Had Received Varying 
Amounts of the Virus Intranasally 
Pneumonia  Iutremasal inoculation  Reinoculafion withintranasallyl0  lethal doses of virus 
virus 
dilution  Died  Survived  Infectivity  Infectivity 
score  score 
10-1 
lo-2 
lO-a 
lo-* 
10-~ 
lO-S 
10-7 
Control 
o  25/5 
1  23/5 
5  6IS 
5  2/5 
5 
5 
5 
Died  Survived 
0  5 
0  5 
3  2 
5  0 
0/5 
0/5 
20/S 
2s/s 
had been inoculated intranasaUy with the pneumonia virus.  Normal mice 
were exposed to those carrying infection at intervals varying from 12 hours 
to 4 days following the intranasal inoculation of the latter and contact was 
continued for an average of 48 hours.  At the end of this time the contact 
mice were removed to clean jars and were observed for an additional 12 
days.  During this period none of the mice developed symptoms sugges- 
tive of infection by the virus, and at autopsy none showed any evidence 
of pulmonary consolidation. 
Susceptibility  Tests with Other Animal Species.--Ferrets  inoculated intranasally with 
10 per cent infected mouse lung suspensions did not develop fever or signs of respiratory 
infection.  Serial passage of suspensions of turbinates and lungs of ferrets which had 
received the virus intranasally did not produce fever or signs of nasal infection in the 
passage animals.  Ferrets which had been inoculated intranasally with this virus were 400  A  PNEUMONIA VIRUS CARRIED BY  NORMAL MICE 
fully susceptible 3 weeks later to the intranasal inoculation of the PR8 strain of epidemic 
influenza  virus.  The virus has been inoculated intranasally in rabbits, guinea pigs, 
rhesus monkeys, voles, deer mice, skunks, woodchucks, opossums, and Syrian hamsters, 
all under ether anesthesia,  and has not produced evidences of infection in any of these 
animals.  It has  been given intraperitoneally to both rabbits and guinea pigs with 
equally negative results.  The results obtained thus far in ten species of animals indi- 
cated that this virus was pathogenic only for mice. 
Cultivation in Vitro.--Attempts were made to cultivate the virus in the minced chick- 
embryo Tyrode medium described by Li and Rivers (16). 
For this purpose either a small peripheral portion of consolidated mouse lung or 0.1 
cc. of a  10 per cent suspension of infected lung was used as the inoculum for the first 
culture.  Transfers to fresh culture media were made at 2 day and 4 day intervals. 
Four strains of the virus have been successfully propagated in chick-embryo Tyrode 
tissue-culture medium.  One strain has been maintained through ten successive trans- 
fers.  All four strains showed a marked reduction in virulence under these conditions, 
and although they were still capable of producing pulmonary consolidation  in mice, 
the pneumonia was seldom fatal. 
Immunization of Mice.--Groups  of mice were actively immunized against 
various strains of the virus by means of two intraperitoneal injections, sepa- 
rated by 14 days, of 0.5  cc. of a  10 per cent suspension of infected mouse 
lungs  in  0.85  per  cent  NaC1.  Other  groups  of  mice  were  actively  im- 
munized in an identical manner against  the PR8 strain of epidemic influ- 
enza virus.  The immunized mice were held for a period of 2 weeks or more 
after the second intraperitoneal injection and were then tested for the pres- 
ence of active immunity by the intranasal  inoculation of various viruses. 
Groups of normal mice of the  same  age  and  from corresponding breeders 
were inoculated simultaneously with the immunized mice to serve as con- 
trols.  Following the intranasal inoculation of the homologous or heterolo- 
gous virus the mice were observed for a  period of 14 days.  At the end of 
this period all surviving mice were killed,  and  their lungs were examined 
for  the  presence of pulmonary  consolidation.  The  results  of these  cross 
immunity  tests,  as  shown  in  Table  V,  are  presented  as  numerical  infec- 
tivity scores which were derived by the method  described above.  It will 
be observed that all strains of the pneumonia virus tested were capable of 
inducing  active  immunity  in  mice  against  all  other  strains  of this  virus. 
The immunity resulting from two intraperitoneal injections of active virus 
has been found to persist for at least 4 months.  None of the mice immun- 
ized with various strains of the pneumonia virus, however, were found to be 
immune to either the  PR8  strain  of epidemic influenza virus or swine in- 
fluenza virus.  Conversely, the mice which had been immunized with the 
PR8 strain of influenza virus were not immune to the pneumonia virus of 
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Neutralization  Tests with the Virus.--In order to detect the presence of specific neu- 
tralizing substances in the serum of normal mice, other animals, or man, neutralization 
tests were carried out in the following manner.  Serial twofold or fourfold dilutions of 
serum to be tested, which  had been inactivated at 56°C.  for 30 minutes immediately 
before dilution, were mixed with constant amounts of the pneumonia virus.  The mix- 
tures were incubated at 370C. for 30 minutes, and immediately thereafter each was given 
intranasally to a group of four to six mice.  The mice were observed for 14 days, and 
the lungs of mice dying during this interval, as well as the lungs of those which survived 
and were killed at the end of the observation period, were examined for pulmonary con- 
solidation.  Neutralization  of the  virus  was  determined  by means of the  numerical 
infectivity score as described above. 
TABLE V 
Results of Cross Immunity Tests with Various Strains of Pneumonia  Virus and the 
Viruses of Human and Swine Influenza 
Immunlzed 
with virus 
Strain 
2 
2  I/6 
5 
15 
16  0/6 
28 
PR8 
Controls  21/6 
Infectivity score 
15 
0/5 
o/s 
1/5 
1/5 
3/5 
2s/s 
23/6 
Pneumonia virus 
Strain 
16 
i 
J 
i  0/s 
0/6 
I  2/5 
i 
I  18/6 
I  30/6 
17 
0/6 
1/5 
30/6 
3/6 
27/6 
Influenza viruses 
Human  Swine 
PR8 strain 
25/5  22/5 
22/5  23/5 
21/5  15/5 
25/5 
0/5  -- 
2s/5  23/s 
Neutralization by Normal Mouse Serum.--A series of neutralization  tests 
was carried out with sera of mice from four different breeders.  Mice from 
three of these were found to carry virus, while those from one breeder were 
negative.  Serum  was obtained  by intracardiac  puncture,  and  the  serum 
from groups of mice from each breeder was pooled separately.  Serum of 
mice 3  and 8 weeks old from each breeder was tested separately.  The re- 
suits  of these  tests,  as  shown  in  Table  VI,  are  expressed in  terms of the 
numerical infectivity score.  It will be seen that  sera of 3  week old mice 
obtained  from breeders  1,  2,  and  3,  which  had  been  shown  to  carry the 
virus, were not  capable of neutralizing  the  virus, nor was the  serum from 
young  mice  obtained  from  breeder  4.  However,  at  8  weeks  of  age  the 
serum of mice from breeder  2  did  neutralize  the  virus,  although  the  sera 
of mice from breeders  1  and  3  did  not.  On  the  other hand,  the  serum of 402  A  PNEUMONIA  VIRUS  CARRIED  BY  NORMAL  MICE 
mice 8 weeks old from breeder 4 also neutralized the virus, even though it 
was shown that young mice from this breeder did not carry the virus. 
These results seem to indicate that  the presence or absence of neutraliz- 
ing substances against the pneumonia virus in the serum of 8 week old mice 
bears no relation  to the presence or absence of the virus in the lungs of 3 
week old mice obtained from the same breeders. 
Neutralization by Human Serum.--Sera  from 67 apparently healthy hu- 
man beings were tested for their capacity to neutralize the pneumonia virus 
of mice.  Twenty-two of these sera, or 33 per cent, were found to neutralize 
100 or more lethal doses of the virus, and a few of the sera were capable of 
neutralizing  this  quantity  of virus in a  dilution  of  I:50.  Many of these 
TABLE  VI 
Results of Neutralization Tests ~th Pneumonia Virus and Normal Mouse Serum 
Mouse breeder  Virus carriers  Age  Serum dilution  Infectivity score 
+ 
+ 
+ 
wks. 
3 
8 
1:2 
1:2 
1:2 
1:2 
1:2 
1:2 
1:2 
1:2 
21/5 
19/5 
23/5 
0/5 
25/5 
18/5 
15/5 
3/5 
sera also were tested for their capacity to neutralize the PR8 strain of in- 
fluenza virus.  No correlation was found between the serum neutralization 
titers against  the pneumonia virus  of  mice  and  epidemic  influenza virus 
respectively. 
Acute and convalescent phase sera obtained from each of fifteen patients 
with various acute respiratory diseases were also tested for their  capacity 
to neutralize  the pneumonia virus of mice.  The results of these tests are 
shown in Table VII, and in each group of mice are expressed as the numer- 
ical infectivity score.  Six of the thirty sera, or 20 per cent, were found to 
neutralize 100 lethal doses of the virus.  In thirteen persons the neutraliza- 
tion titer of the acute phase serum was the same as that of the convalescent 
phase serum.  However, with the sera obtained from two patients with so 
called  "atypical pneumonia"  the  results with  the  acute  and  convalescent FRANK L.  HORSFALL, JR.,  AND  RICHARD G.  HAHN  403 
phase  sera  were  different.  The serum  of one of  these patients  increased 
in titer during convalescence, while that of the other showed a  decrease in 
titer  during  convalescence. 
Neutralization  by Specific  Antiserum.-- 
Rabbits, from which normal serum had been obtained as a control,  were immunized 
by a  single intraperitoneal injection  of 3.0 cc. of a  10 per cent suspension  of infected 
mouse lungs in 0.85 per cent NaC1 or 3.0 cc. of a tissue culture supernatant containing 
the active virus.  10 or 12 days later serum was again obtained by intracardiac puncture. 
Rabbit antisera prepared in this manner against each of eight strains  of the pneumonia 
TABLE VII 
Results of Neutralization  Tests with Pneumonia Virus and Human Sera Obtained during 
A cute and Convalescent Phases of Various Acute Respiratory Diseases 
Acute respiratory disease 
Clinical diagnosis 
Common cold 
Sporadic grippe 
Epidemic influenza 
c~  ~c 
Atypical pneumonia 
Pneumococcus pneumonia 
Serum 
Phase 
Acute 
Convalescent 
Acute 
Convalescent 
Acute 
Convalescent 
Acute 
Convalescent 
Acute 
Convalescent 
Dilution 
1:2 
1:2 
1:2 
1:2 
15/4 
12/4 
11/4 
20/4 
1:2  8/4 
1:2  4/4 
1:2 
1:2 
1:2 
1:2 
15/4 
S/4 
20/4 
20/4 
Infectivity  score 
Cas~ 
20/4 
12/4 
4/4 
0/4 
8/4 
11/4 
13/4 
15/4 
18/4 
20/4 
10/4 
14/4 
2/4 
2/4 
10/4 
7/4 
3/4 
12/4 
15/4 
13/4 
virus of mice were tested for their capacity to neutralize the homologous as well as various 
heterologous  strains.  Certain of these  antisera were also tested for their capacity to 
neutralize  human and  swine  influenza  viruses.  Rabbit  antisera,  similarly  prepared, 
against  the PR8 strain  of epidemic  influenza  virus or swine influenza  virus,  and the 
serum  of rabbits which had received  10 per cent suspensions  of normal mouse lungs 
intraperitoneally 12 days previously, were also tested against various strains of the pneu- 
monia virus of mice. 
The results of these cross neutralization tests are presented in Table VIII 
and,  in  each  group of mice,  are  expressed  as numerical infectivity scores. 
It will'be  noted  that  each  antiserum  neutralized  all  strains  of  this  virus 
against  which  it  was  tested,  but  not  human  or  swine  influenza  viruses. 404  A  PNEUMONIA  VIRUS  CARRIED  BY  NORMAL  MICE 
The antisera against the PR8 strain of influenza and swine influenza viruses 
failed to neutralize any of the strains of the pneumonia virus.  The serum 
of rabbits injected with  suspensions of normal  mouse lungs also failed to 
neutralize the pneumonia virus. 
Specific ferret and  rabbit antisera  against  a  large  number  of strains  of 
epidemic influenza virus, including such well known strains as PRS, W. S., 
Talmey, and Gatenby, as well as certain strains isolated during  lq39  (17), 
were also tested for their capacity to neutralize the pneumonia virus.  None 
of these, when diluted 1: 10 or more, was capable of neutralizing  100 lethal 
TABLE  VIII 
Results of Cross Neutralization  Tests with Various Strains of Pneumonia Virus and the 
Viruses of Human and Swine Influenza 
Antiserum  Infectivity score 
Strain 
2 
7 
15 
16 
17 
25 
27 
28 
PR8 
Swine 
Mouse lung 
Control 
Dil 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
ttion 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
:2 
2 
0/5 
2/5 
0/5 
0/5 
0/5 
0/5 
2/S 
13/S 
161s 
17/5 
Pneumonia virus 
Strain 
15 
2/5 
2/5 
3/5 
2/5 
o/s 
5/s 
4/5 
25/5 
20/4 
21/5 
2s/s 
i  6  17 
1/s  o/s 
o/s  o/s 
o/s  1/s 
OlS  OlS 
o/s  o/s 
o/s  1/s 
OlS  11s 
2s/s  -- 
23/s 
2s/s  18/s 
25/s  22/s 
28 
2s/s 
2s/s 
Influenza viruse~ 
Human  Swine  PR$  strai__._  n 
2o/5 
2s/s  -- 
22/5 
2s/s  -- 
2s/s  -- 
o/s  -- 
o/5 
2s/s  2s/s 
doses of this virus.  However, in a dilution of 1: 2, some anfisera produced 
against Brooklyn 15 strain  (18) and strain  149  (17) of influenza virus were 
found  to  neutralize  the  pneumonia  virus.  The  possibility that  either  of 
these  strains  was  contaminated  with  the  pneumonia  virus  was  excluded 
since neither had been carried in mice. 
These  results  seem to  indicate  that  all  strains  of the  pneumonia  virus 
which  have  been  tested  were  immunologically  identical.  They  indicate 
also that the pneumonia virus of mice was not related anfigenically to either 
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DISCUSSION 
Besides their  importance to natural  history, the group of viruses now 
known to occur in the lungs of apparently healthy mice have definite prac- 
tical significance.  The fact that these agents are entirely avirulent as they 
occur naturally and develop virulence only after serial mouse passage adds 
considerably to the difficulty of determining their presence.  The possibil- 
ity that they may exist in almost any stock mice complicates the interpre- 
tation  of pulmonary consolidations observed after serial  mouse passage. 
Since serial passage is usually necessary before epidemic influenza virus can 
be established in mice (19,  20),  there exists  the possibility that a  mouse 
lung virus may be encountered during the process.  Although it has not 
been  difficult to  distinguish between  this  pneumonia virus of  mice  and 
epidemic influenza virus,  there  is  evidence indicating that  mouse lungs 
may contain other viruses which are less readily differentiated from influ- 
enza virus. 
It seems probable that the virus isolated from the lungs of mice in this 
laboratory is  quite different from the viruses which have been described 
previously by  Dochez,  Mills,  and  Mulliken  (5)  and  Gordon,  Freeman, 
and Clampit (6).  These latter agents were readily encountered in rapid 
(4 to 5 day) serial mouse passages, whereas the virus described herein was 
recoverable only when slow (7 to 9 day) serial mouse passages were made. 
Furthermore,  the  course  of  the  disease  was  relatively  rapid  with  those 
viruses which have been described by other investigators (5,  6)  and mice 
usually died in 2  to 4  days.  The virus described in this communication 
seldom killed mice before the 8th day after inoculation irrespective of the 
quantity  of  virus given.  Dochez, Mills, and Mulliken (5)  reported  that 
their virus was infectious for ferrets  and produced high fever and nasal 
symptoms in these animals.  Our virus, on the other hand, was entirely 
non-infectious for ferrets and did not become infectious for this species even 
after  a  number of  serial  ferret  passages.  Most  significant,  perhaps,  as 
evidence of the differences is the fact that those viruses described by previ- 
ous investigators (5,  6)  were either non-antigenic or were very poor anti- 
gens and failed to immunize mice against themselves.  They also failed to 
produce neutralizing antisera after injection into rabbits.  The virus de- 
scribed in this report readily immunized mice after either intraperitoneal or 
intranasal inoculation and produced satisfactory neutralizing antisera when 
injected into rabbits. 
The strict pneumotropism of the virus for mice and its complete aviru- 
lence for  any other species of  animals studied seems to  distinguish this 406  A  PNEUMONIA  VIRUS CARRIED  BY NORMAL  MICE 
virus from others known to occur in normal mice.  On this basis its differ- 
ences from infectious ectromelia virus  (1),  lymphocytic choriomeningitis 
virus  (2,  3),  and mouse encephalomyelitis virus  (4)  seem obvious.  The 
agent  can  also  readily be  differentiated from meningopneumonitis virus 
(21),  psittacosis  virus  (22),  and  lymphogranuloma inguinale  virus  (23) 
since  all of these agents possess  characteristics which are quite  different 
from those of the pneumonia virus of mice. 
If there are,  as there seem to  be,  at least two different pneumotropic 
viruses present in the lungs of certain apparently healthy mice, the inter- 
pretation of pulmonary consolidation produced in mice by serial passage 
becomes hazardous unless the causal agent can be positively identified by 
means of specific neutralization tests. 
How and from what source this virus gains access to the lungs of mice are 
unknown.  However, there is some evidence which suggests that the orig- 
inal  source of  the  virus  was  not  mice  themselves.  Three  of  the  eight 
breeders whose mice were studied during the course of this investigation 
received their original stock mice from one source.  It is known that the 
progeny of mice from this common source do not now carry the virus.  It 
has been shown, however, that the mice obtained from one of these three 
breeders regularly carried the virus and that those from the other two did 
not.  This might be taken to indicate that those mice which now carry the 
virus became infected after they had been acquired by the breeder in ques- 
tion and that young mice from this stock either acquired the virus from 
their mothers or were regularly infected from another source.  That this 
other source might actually be human beings is suggested by the fact that 
approximately 30 per cent of normal human sera are capable of neutralizing 
the virus.  In view of the large body of evidence which has been assembled 
in support of the specificity of the neutralization test in many other virus 
infections, it seems unreasonable to overlook the possible significance of the 
results obtained with  this virus.  However, if the virus is  derived from 
human beings, it probably does not have any etiological  relationship to the 
five different acute respiratory infections which were studied since no defi- 
nite evidence was obtained of an increase in neutralizing antibodies against 
the virus during convalescence from these infections. 
SUMMARY 
1.  A virus capable of producing fatal pneumonia in mice has been iso- 
lated repeatedly from the lungs of certain apparently healthy mice.  Not 
all mice carry the virus.  It was obtained only from mice supplied by three 
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2.  The  virus  was  avirulent  as  it  occurred in  normal mouse lungs  and 
became virulent only after serial mouse lung passage.  It was strictly pneu- 
motropic for mice and produced pneumonia when given intranasally but 
showed no evidence of infection when given by other routes.  The virus 
was  non-infectious for  ferrets  and  did  not  become  pathogenic  for  this 
species  after  numerous  serial  passages.  It  was  also  non-pathogenic  for 
rabbits,  guinea  pigs,  rhesus  monkeys,  voles,  deer  mice,  skunks,  wood- 
chucks, opossums, and Syrian hamsters. 
3.  All strains of the virus which have been tested have been immunolog- 
ically identical, as indicated both by cross immunity and cross neutraliza- 
tion  tests  in  mice. 
4.  The virus was antigenic both in mice and in rabbits and was readily 
differentiated from viruses of human influenza and of swine influenza by 
means of either cross immunity or cross neutralization tests. 
5.  The virus was also neutralized by about 30 per cent of normal human 
sera tested. 
6.  The virus was extremely labile, and suspensions prepared in saline or 
broth became inactivated within a  few hours at room temperature.  The 
addition of normal horse serum to the virus suspensions, however, exerted 
a  definite stabilizing  effect. 
7.  Ultrafiltration results indicated that the virus particles have a  diam- 
eter of about  100  to  150 millimicrons. 
8.  Evidence is presented which indicates that this virus is different from 
other  viruses  which  various  investigators  have  found  in  normal  mouse 
lungs. 
The authors are indebted to Dr. Thomas M. Rivers and Dr. Colin M. MacLeod of 
the Hospital of The Rockefeller Institute for many of the sera obtained from patients 
with various acute respiratory infections. 
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